Form 13-F position report

* DOLBY LABORATORIES INC

Reported by RAYMOND JAMES & ASSOCIATES

DLB CUSIP 25659T107 Manager CIK 0001084208

Reported 280,162 shares, up 526 (0.2%) from the prior quarter.

Reported value 6.6%; share count 0.2% vs. the prior quarter.

Added
% of reported 13F value 0.02% This manager · Q4 2019
Shares 280,162 Quarter-end amount reported
Reported value $19,275,000 Fair value at quarter end
Consecutive quarters held 27 Through Q4 2019

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2019-12-31 19275000
2020-03-31 9340000
2020-06-30 10823000
2020-09-30 10501000
2020-12-31 10779000
2021-03-31 10915000
2021-06-30 10547000
2021-09-30 9822000
2021-12-31 10400000
2022-03-31 8174000
2022-06-30 11848000
2022-09-30 24433000
2022-12-31 34050740
2023-03-31 41490752
2023-06-30 40616726
2023-09-30 39429604
2023-12-31 43335769
2024-03-31 40741488
2024-06-30 37338756
2024-09-30 487964

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for * DOLBY LABORATORIES INC held by RAYMOND JAMES & ASSOCIATES.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2024 Reduced 6,376 -464,894 (-98.6%) < 0.01% $487,964 2024-10-18
Q2 2024 Reduced 471,270 -15,079 (-3.1%) 0.02% $37,338,756 2024-07-19
Q1 2024 Reduced 486,349 -16,503 (-3.3%) 0.03% $40,741,488 2024-04-22
Q4 2023 Added 502,852 +5,380 (1.1%) 0.03% $43,335,769 2024-01-16
Q3 2023 Added 497,472 +12,090 (2.5%) 0.03% $39,429,604 2023-10-24
Q2 2023 Reduced 485,382 -344 (-0.1%) 0.03% $40,616,726 2023-07-25
Q1 2023 Added 485,726 +3,011 (0.6%) 0.04% $41,490,752 2023-04-14
Q4 2022 Added 482,715 +107,688 (28.7%) 0.03% $34,050,740 2023-02-08
Q3 2022 Added 375,027 +209,454 (126.5%) 0.02% $24,433,000 2022-10-25
Q2 2022 Added 165,573 +61,070 (58.4%) 0.01% $11,848,000 2022-08-12
Q1 2022 Reduced 104,503 -4,718 (-4.3%) < 0.01% $8,174,000 2022-05-11
Q4 2021 Reduced 109,221 -2,397 (-2.1%) < 0.01% $10,400,000 2022-02-08
Q3 2021 Added 111,618 +4,318 (4.0%) < 0.01% $9,822,000 2021-11-02
Q2 2021 Reduced 107,300 -3,263 (-3.0%) < 0.01% $10,547,000 2021-08-11
Q1 2021 Reduced 110,563 -417 (-0.4%) 0.01% $10,915,000 2021-05-14
Q4 2020 Reduced 110,980 -47,455 (-30.0%) 0.01% $10,779,000 2021-02-12
Q3 2020 Reduced 158,435 -5,876 (-3.6%) 0.01% $10,501,000 2020-11-04
Q2 2020 Reduced 164,311 -7,976 (-4.6%) 0.01% $10,823,000 2020-07-28
Q1 2020 Reduced 172,287 -107,875 (-38.5%) 0.01% $9,340,000 2020-04-21
Q4 2019 Added 280,162 +526 (0.2%) 0.02% $19,275,000 2020-02-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

319 managers reported * DOLBY LABORATORIES INC for Q4 2019.

Managers reporting * DOLBY LABORATORIES INC in Q4 2019.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 5,800,278 +26,624 0.01% $399,059,000 27 qtrs
Clearbridge Investments LLC Reduced 4,526,817 -501,743 0.26% $314,433,000 27 qtrs
JANUS HENDERSON GROUP PLC Reduced 4,409,628 -15,923 0.16% $303,382,000 15 qtrs
BlackRock Inc Added 3,067,936 +174,472 < 0.01% $211,076,000 27 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 2,114,557 -298,443 0.11% $145,482,000 27 qtrs
MACKENZIE FINANCIAL CORP Added 1,859,742 +99,091 0.31% $127,950,000 8 qtrs
DISCIPLINED GROWTH INVESTORS INC MN Added 1,816,469 +53,704 2.06% $124,973,000 27 qtrs
Thrivent Financial for Lutherans Added 1,709,456 +136,875 0.33% $117,610,000 13 qtrs
ALLIANCEBERNSTEIN L P Reduced 1,403,504 -261,230 0.05% $96,561,000 27 qtrs
BLAIR WILLIAM & CO IL Added 1,317,649 +23,052 0.47% $90,654,000 12 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2019
Filed
February 12, 2020
Filing type
13F-HR
Position type
COM CL A

Voting authority reported

Sole
275,745
Shared
0
None
4,417

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.